Cantel Medical (CMN) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Piper Jaffray Raises Price Target on Cantel Medical (CMN) Following 3Q15
June 10, 2015 8:21 AM EDTPiper Jaffray reiterates an Overweight rating on Cantel Medical (NYSE: CMN), and raised the price target to $60.00 (from $49.00), following 3Q15. CMN reported sales of $141.5M, which was $5.5M above forecast. Earnings were $0.35, 2 cents above estimates.
Analyst Thomas Gunderson commented, "Strong sales growth of 18% was led by the Endoscopy (up 35%) and Water Purification... More
